Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 4.35 4.30 4.40 4.35 4.35 4.35 208,206 07:35:43
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.2 -1.0 - 12

Evgen Pharma Share Discussion Threads

Showing 11026 to 11049 of 11475 messages
Chat Pages: Latest  447  446  445  444  443  442  441  440  439  438  437  436  Older
DateSubjectAuthorDiscuss
28/11/2022
10:15
Today's news from C4X on their new collaboration with Astra Zeneca for their NRF2 activator program ($400m milestones plus royalties) is encouraging for Evgen as it validates the importance of NRF2 activation to big pharma and Sulforaphane's principal mechanism of action is through NRF2 activation 🙂

https://uk.advfn.com/p.php?pid=quote&;symbol=L%5EC4XD

timbo003
28/11/2022
09:45
It Won't be long MD, I'm expecting way past 7p if I'm honest.
georgie pie
28/11/2022
09:42
I've had a decent stake here for a while. A bit more news and this will be 7p+
manual dexterity
28/11/2022
09:23
Smithie6 - I agree with your sentiments on the length of the main presentations but I would prefer to see them spend more time answering questions than droning on over pointless graphs.

Also as you say a very clear picture of them at all times in a 50/50 window maybe, as their general approach and even expressions can leave one with positive or negative views of them.

Still good to see a few buys rolling in early this morning and just one MM left on offer at 5.40 then a jump to 5.70p at present.

clocktower
28/11/2022
08:37
Longevity...GENF


Here's why this UK BioTech stock could be set to rally over 2000%

https://clearcapitalmarkets.co.uk/biotech-opinion-joe-neighbour/?gclid=EAIaIQobChMInZjjq4TP-wIVhLTtCh3iWQGBEAAYASAAEgIBGfD_BwE

moneymunch
27/11/2022
21:25
...you are right, it is mostly an error from the production company ("investor meets company" I think); which is suprising since presentation is in theory a large part of their job (& in theory skills).

(I have a standard size smart phone, fixed screen not folding.
The production co. needs to ensure , imo, that presentation is ok on smartphones since a good % of views will be on smartphones imo)

-----
I tried to watch a presentation from another company. But it was 1 hour long & the MD was droning on & on.
imo another mistake from the same production company.
Personally I don't think that potential investors are willing to use 1 hour to watch introduction video presentations lasting 1 hour ! And imo production companies should know that.
The EVG video is almost tolerable at ~35 minutes long, but still too long imo. 20 minutes should be enough.

smithie6
27/11/2022
19:59
Smithie6, I think this is something that the directors should take onboard but the people that should address the issues you have raised are the production company but I trust you will be notifying the company, and then if they do nothing to ensure that the problems are not repeated, it will be justifiable to be critical of the company.

By the way do you only have one of those small folding fashionable phones rather than the likes of one that is almost as large as a mini iPad. :-)

clocktower
27/11/2022
16:29
Try watching on a larger screen then a phone perhaps?
on target
27/11/2022
16:15
Simple solution Smithie go and invest in Netflix
senttothegallows
27/11/2022
15:57
just been trying to listen/watch the presentation/interview, that is on the web & someone provided a link to.

hTTps://www.youtube.com/watch?v=N0argjsE-fw

I wasn't very impressed by the technical quality of the video presentation.
On a standard smartphone the 3 directors occupied a miniscule box of ~20mm x ~10mm !!, a tiny fraction of the smartphone screen.

Investors are putting their money at risk by backing these directors. The least they can do is show their faces imo. & "report" to shareholders, & not hide themselves in a tiny 20mmx 10mm area.

One needs a microscope if want to expand/see that. Most of the screen is occupied by a static std. screen saying the name of the company.

0/10.

- sound level, too low. 1/10.

- sound quality. poor. very high echo, making it much harder to listen. 1/10.

Slides/viewfoils.
- blurred text !
many viewfoils can not be read because the nlurring is so bad !
on a smartphone !
I would understand it being a bit blurred if I was projecting on to a wall & making it 1 metre wide, but on a smartphone there is no excuse for the text being blurred imo. 1/10

- green text font on a white background.
difficult to read/see. 1/10.

Overall score.
1/10.

smithie6
24/11/2022
15:23
probably just a few closing positions, not much volume at all. still above 5 just awaiting next news to launch this into orbit.
georgie pie
24/11/2022
14:35
Disappointing to see it sliding backwards once again.
clocktower
24/11/2022
07:35
It could well break 6p today imho, news draws closer every day.
georgie pie
23/11/2022
12:38
Next RNS could catapult this sharply northwards
georgie pie
23/11/2022
12:14
Looking nice
givmesunshine
23/11/2022
12:12
He can almost buy a pint of lager in Qatar with that profit.
georgie pie
23/11/2022
11:20
Nice to see us bounce up and holders keen to stay/ accumulate at these levels
givmesunshine
23/11/2022
11:10
Laughing at the auction trader buying 3179 and selling instantly for £12 profit
dave4545
23/11/2022
10:12
As mentioned I'm not in here but that chart is looking very tasty. A close of 5.5p or above and I think you'll see a significant move.
parob
23/11/2022
10:02
Yup that's an understatement.. holding and waiting - GLA
givmesunshine
23/11/2022
09:34
No free float here
mick1909
22/11/2022
07:22
Morning - agree - great potential here and very much funded with more to come - it's a solid hold and wait .. could be multiples within a year
givmesunshine
21/11/2022
23:39
I think this is an interesting share. The deal with the Swiss company to pay $1m plus royalties was fantastic news, to have significant money rolling in whilst working on the other projects felt like the start of something exciting for Evgen.
I’m not saying it’s a given that this will be a winner but I think there is enormous potential for little risk over the next year or two.
Half year report due in a fortnight’s time, I would be surprised if it wasn’t positive. Definitely a share I am happy to have for the next year or so to see if they can hit the jackpot.

terrydevlin1
17/11/2022
16:57
Added on the dip - thanks very much sellers :)
on target
Chat Pages: Latest  447  446  445  444  443  442  441  440  439  438  437  436  Older
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230209 06:23:15